In the management of HPV+ cancers
A Simple, Innovative Blood Test Is Helping Physicians Personalize HPV-Positive Cancer Care
If you have HPV+ throat (oropharyngeal) or anal cancer
Your Blood TTMV®
Can Guide the Way
In the management of HPV+ oropharyngeal or anal cancer
Let Their Blood TTMV® Guide You
Tumor tissue modified viral (TTMV®)-HPV DNA
a Unique Biomarker for Human Papillomavirus
(HPV)-Driven Cancers
NavDx® is an innovative blood test helping physicians personalize care during every phase of
treatment for people with HPV-positive cancers like oropharyngeal (head and neck) or anal cancer
Pretreatment
Confirm the HPV genotype and baseline TTMV-HPV DNA level
During Treatment
Assess response to treatment and determine if there is any molecular residual disease post treatment
Recurrence Monitoring
Detect cancer recurrence earlier than imaging or physical exam
Blood TTMV®
Tumor tissue modified viral (TTMV®)-HPV DNA is a unique human papillomavirus
(HPV)-driven cancer biomarker that dying tumor cells release into the blood
- TTMV-HPV DNA is found in people with HPV-positive (HPV+) cancers, like those of the mouth or throat (oropharyngeal cancer), making it an ideal biomarker
- Measuring and tracking blood TTMV Score gives physicians valuable information about the status of HPV+ cancer
Optimize the clinical management of HPV+ cancer across the patient care continuum
Routine testing with NavDx to track and monitor changes in blood TTMV offers a more complete picture of a patient's HPV-driven cancer status than simply relying on physical exams and imaging
Learn more about routine testing with NavDx
Getting started with NavDx is easy
Start the
conversation with
your physician
Order NavDx for your HPV+ cancer patients
Monitor and track their blood TTMV across the care continuum
Stay Connected
Sign up for updates on the latest NavDx developments in HPV+ cancer detection and monitoring
We’re here to help!
If you have any questions or would like to know more, contact us or see our FAQs
The
Naveris CaresTM
Program
Naveris is committed to ensuring NavDx is accessible for all appropriate patients with HPV-positive cancer by providing support services and financial assistance to those who qualify.
Frequently asked questions (FAQs) regarding NavDx testing
Get the answers to the most common questions regarding TTMV testing with NavDx and related topics.
Contact Us
To connect with NavDx Client Services, please email, or call Client Services directly at (833) 628-3747 with any questions.